Company
United StatesPublic company, NASDAQ: MIRMMirum Pharmaceuticals, Inc. (NASDAQ: MIRM), Foster City, CA – FDA Inspections
Inspection records and compliance data for Mirum Pharmaceuticals, Inc. in Foster City, California. 4 FDA inspections on record, 1 Form 483, last inspected July 24, 2026. Publicly traded as NASDAQ: MIRM.
Company Profile
This profile covers Mirum Pharmaceuticals, Inc. based in Foster City, California, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected May 12, 2021. Last inspected July 24, 2026.
Most cited issue areas
- Late submission of 15-day report1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 24, 2026 | Not classified | Human Drugs · Postmarket Surv. and Epidemiology | 1328024 |
| December 5, 2024 | Not classified | Human Drugs | 1259153 |
| October 3, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1220683 |
| May 12, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1142794 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Mirum Pharmaceuticals, Inc.
Stock ticker
MIRM
Exchange
NASDAQ
Share price
$93.33
Market cap
$6.1B
Price as of
November 13, 2026
FEI Number
3015282580
Address
989 E Hillsdale Blvd Ste 300, Foster City, California 94404, United States
Country
United States
ID: 9b906e94-ef88-467f-8b15-9f0b02d9e49d